Atlas Trials

Phase 1

65,473 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 1

RecordFirmDate
Extension Study of AGT-181-102 to Evaluate Long Term Safety and Activity of AGT-181 (NCT02597114)ArmaGen, Inc2015-11-01
The Safety and Maximum Tolerated Dose of Axitinib in Combination With Radiotherapy for HCC (NCT02814461)Shin Kong Wu Ho-Su Memorial Hospital2015-11-01
A Study to Assess the Effect of Multiple-Dose Administration of JNJ-42847922 on Midazolam and Warfarin in Healthy Participants (NCT02617810)Janssen Research & Development, LLC2015-11-01
The Use of Ambulatory Blood Pressure Monitors to Assess Angiotensin Converting Enzyme Inhibitors (NCT02623036)Memorial Health University Medical Center2015-11-01
A Study of LY3200327 in Healthy Participants (NCT02595736)Eli Lilly and Company2015-11-01
CAR-T Cell Immunotherapy in MUC1 Positive Solid Tumor (NCT02617134)PersonGen BioTherapeutics (Suzhou) Co., Ltd.2015-11-01
Safety, Tolerability, and Immunogenicity of a Cytomegalovirus DNA Vaccine (NCT02594566)Virginia Commonwealth University2015-11-01
Phase 1 TAK-915 Single-Dose Positron Emission Tomography (PET) Occupancy Study (NCT02584569)Takeda2015-11-01
Single Ascending Dose Study of TD-0714 in Healthy Subjects (NCT02639078)Theravance Biopharma2015-11-01
Strategy of UltraProtective Lung Ventilation With Extracorporeal CO2 Removal for New-Onset Moderate to seVere ARDS (NCT02282657)European Society of Intensive Care Medicine2015-11-01
MAGE A10ᶜ⁷⁹⁶T for Advanced NSCLC (NCT02592577)Adaptimmune2015-11-01
Healthy Volunteer Solid Oral Dose and Multiple Ascending Dose Evaluation of CTP-656 (NCT02599792)Concert Pharmaceuticals2015-11-01
Single and Multiple Ascending Doses Clinical Pharmacology Study With KAR5585 (NCT02746237)Karos Pharmaceuticals2015-11-01
Seasonal Trivalent Inactivated Split Virion Influenza Vaccine Clinical Trial (IVACFLU-S) (NCT02598089)Institute of Vaccines and Medical Biologicals, Vietnam2015-11-01
Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers (NCT02933658)Daewon Pharmaceutical Co., Ltd.2015-11-01
Study Evaluating Duvelisib in Japanese Subjects With Relapsed or Refractory Lymphoma (NCT02598570)AbbVie2015-11-01
A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies (NCT02498665)Sumitomo Pharma America, Inc.2015-11-01
Fmri-based Neurofeedback With Anxious Adolescents Study (NCT02463136)University of Oxford2015-11-01
A Multi-Center, Open-Label Study of Surufatinib (HMPL-012) in Patients With Advanced Solid Tumors (NCT02549937)Hutchmed2015-11-01
Triferic Pediatric Pharmacokinetic Protocol (NCT02595437)Rockwell Medical Technologies, Inc.2015-11-01
A Study of a Seasonal Trivalent Split, Inactivated Influenza Vaccine (NCT02585700)Institute of Virology, Vaccines and Sera, Torlak2015-11-01
RDEA3170 PK/PD Study (NCT02608710)Ardea Biosciences, Inc.2015-11-01
Dextromethorphan Effect on Central Sensitization to Pain in Healthy Volunteers (NCT02596360)University Hospital, Clermont-Ferrand2015-11-01
Neoadjuvant MEDI4736 Concomitant With Weekly Nab-paclitaxel and Dose-dense AC for Stage I-III Triple Negative Breast Cancer (NCT02489448)Yale University2015-11-01
Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-55375515 in Healthy Participants (NCT02623491)Janssen Research & Development, LLC2015-11-01
To Determine Blood Concentrations of Ibuprofen and Caffeine in a Tablet Against Ibuprofen Alone From Another Tablet (NCT02629354)Boehringer Ingelheim2015-11-01
First-in-Human Single and Multiple Dose of GLPG1972 (NCT02612246)Lakefront Biotherapeutics NV2015-11-01
Tranexamic Acid and Ethamsylate For Preventing PPH in Patient Undergoing LSCS at High Risk For PPH (NCT02604719)Ahmed Alanwar2015-11-01
Pilot Pharmacokinetic Study of a Prolonged-release Formulation of St. John's Wort Extract Ze 117 (NCT02505191)Max Zeller Soehne AG2015-11-01
OPEN-LABEL, MULTI-CENTER, PHASE 1b/2a CLINICAL TRIAL DESIGNED TO EVALUATE THE SAFETY AND EFFICACY OF IONTOPHORETIC DEXAMETHASONE PHOSPHATE OPHTHALMIC SOLUTION IN PATIENTS HAVING UNDERGONE CATARACT SURGERY WITH IMPLANTATION OF A POSTERIOR CHAMBER INTRAOCULAR LENS (IOL) (NCT02571556)Eyegate Pharmaceuticals, Inc.2015-11-01
Community Health Assessment Program in the Philippines (NCT02479516)McMaster University2015-11-01
A Safety and Immunogenicity Trial of IHV01 (NCT02756208)University of Maryland, Baltimore2015-11-01
BIO 300 Non-Small Cell Lung Cancer Study (NCT02567799)Humanetics Corporation2015-11-01
Study of KHK2375 in Subjects With Advanced or Recurrent Breast Cancer (NCT02623751)Kyowa Kirin Co., Ltd.2015-11-01
Study to Evaluate Pharmacokinetics of A Modified Release Formulation of PF-06650833 in Healthy Subjects (NCT02609139)Pfizer2015-11-01
An Exploratory Trial Investigating the Neurogenic Component in Psoriasis Vulgaris by Use of Botulinum Toxin A (NCT02577185)LEO Pharma2015-11-01
A RCT COMPARING LACTULOSE AND RIFAXIMIN ASSOCIATED WITH A VEGETABLE DIET IN THE PREVENTION OF POST-TIPS OVERT HEPATIC ENCEPHALOPATHY (NCT02931123)University of Roma La Sapienza2015-11-01
Tolerance to NeuroEPO in Parkinson Disease (NCT04110678)International Center for Neurological Restoration, Cuba2015-11-01
Safety and Effectiveness of Novel Nitroglycerin Based Catheter Lock Solution (NCT02577718)Novel Anti-Infective Technologies, LLC2015-11-01
A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies (NCT02571036)Deciphera Pharmaceuticals, LLC2015-11-01
Pediatric FEcal Microbiota Transplant for Ulcerative Colitis (NCT02487238)McMaster Children's Hospital2015-11-01
Safety and Efficacy of rAAV.hCNGA3 Gene Therapy in Patients With CNGA3-linked Achromatopsia (NCT02610582)STZ eyetrial2015-11-01
A Drug-drug Interaction Study Between Daclatasvir and Atazanavir/Ritonavir or Atazanavir/Cobicistat (NCT02565888)Radboud University Medical Center2015-11-01
Study to Evaluate the Effect of Lemborexant Versus Placebo on Driving Performance in Healthy Adult and Elderly Subjects (NCT02583451)Eisai Inc.2015-11-01
A Study of the Safety and Efficacy of EBV Specific T-cell Lines (NCT02580539)Dr. Jean-Sebastien Delisle, MD, PhD2015-11-01
Study of the Safety of QRH-882260 Heptapeptide (NCT02574858)University of Michigan2015-11-01
Bioavailability Food-Effect Study of an Oral Nitisinone Formulation to Treat Hereditary Tyrosinemia (HT-1) (NCT02750332)Cycle Pharmaceuticals Ltd.2015-11-01
Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced Intensity Donor Hematopoietic Cell Transplant in Patients With Myelofibrosis (NCT02528877)City of Hope Medical Center2015-11-01
Metformin And Chloroquine in IDH1/2-mutated Solid Tumors (NCT02496741)Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2015-11-01
Intralesional Tolerogenic Dendritic Cells in Crohn's Disease Treatment (NCT02622763)Fundacion Clinic per a la Recerca Biomédica2015-11-01
Pharmacokinetics (PK), Pharmacodynamics (PD), Safety, Tolerability of Multiple Dose Regimens of MT-3724 for the Treatment of Patients With Relapsed Chronic B-cell Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT02556346)Molecular Templates, Inc.2015-11-01
Compare Pharmacokinetic(PK) Profiles of XZK vs Lovastatin in Healthy Male Volunteers (NCT02603770)Luye Pharma Group Ltd.2015-11-01
A Study to Evaluate the PK, Safety and Tolerability of GMI-1271 With and Without Filgrastim in Healthy Adult Subjects (NCT02703051)GlycoMimetics Incorporated2015-11-01
Investigate a Interaction of Candesartan and Atorvastatin in Healthy Male Sugjects (NCT02609711)Ahn-Gook Pharmaceuticals Co.,Ltd2015-11-01
Phase 1b/2 Study of the Combination of IMCgp100 With Durvalumab and/or Tremelimumab in Advanced Cutaneous Melanoma (NCT02535078)Immunocore Ltd2015-11-01
131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients (NCT02602067)sigma-tau i.f.r. S.p.A.2015-11-01
A Multiple Ascending Dose Study With a Dose Formulation Comparison Cohort to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects (NCT02606214)Global Alliance for TB Drug Development2015-11-01
Variability in Response to Non-steroidal Anti-inflammatory Drugs (NCT02502006)University of Pennsylvania2015-11-01
PRTX-100-203 Open-Label, Dose Escalation Study in Adult Patients With ITP (NCT02566603)Protalex, Inc.2015-11-01
Minocycline Therapy for Management of Adverse Radiation Effects (NCT02201563)University of Pittsburgh2015-11-01
Mass Balance Recovery and Metabolic Profile of 14C Debio 1450 Following Single Oral and Intravenous Doses in Healthy Male Subjects (NCT02595203)Debiopharm International SA2015-11-01
Therapy of Preconditioned Autologous BMMSCs for Patients With Ischemic Heart Disease (NCT02504437)Academy Military Medical Science, China2015-11-01
Pharmacokinetics of Doxorubicin in cTACE of Liver Cancer (NCT02753881)Yale University2015-11-01
Pharmacokinetics and Pharmacodynamics Comparison Study Between Two Pegfilgrastim Formulations (NCT02589301)Eurofarma Laboratorios S.A.2015-11-01
Multiple-dose Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis (NCT02559934)G&E Herbal Biotechnology Co., LTD2015-11-01
Video Feedback Intervention for Cognitively Impaired Older Drivers (NCT02600026)Rhode Island Hospital2015-11-01
Comparison of the Pharmacokinetics of Tiotropium Delivered From Test Inhaler Products With Two Reference Products (NCT02627625)Solventum US LLC2015-11-01
A Bioequivalence Study of Darunavir, Emtricitabine, and Tenofovir Alafenamide, in the Presence of Cobicistat in Healthy Participants (NCT02578550)Janssen Sciences Ireland UC2015-11-01
Pharmacokinetics of TD-4208 in Patients With Moderate Hepatic Impairment (NCT02581592)Mylan Inc.2015-11-01
Bioequivalence Study of Fentanyl Transdermal System (JNJ-35685-AAA-G021) Compared With DURAGESIC Fentanyl Transdermal Patch in Healthy Participants (NCT02617758)Janssen Research & Development, LLC2015-11-01
Assessment of the Safety of Allogeneic Umbilical Cord Blood Infusions in Children With Cerebral Palsy (NCT02599207)Joanne Kurtzberg, MD2015-11-01
Autologous Bone Marrow Derived Mesenchymal Stromal Cells Transplantation(BM-MSC) for Kienbock's Disease (NCT02646007)Royan Institute2015-11-01
Single Dose Study of SHR4640 in Healthy Subjects (NCT02815839)Jiangsu HengRui Medicine Co., Ltd.2015-11-01
Study to Assess the Effect of Multiple Doses of Tradipitant on CYP3A4 Using Midazolam as a Substrate in Healthy Subjects (NCT02621385)Vanda Pharmaceuticals2015-11-01
HSV529 Vaccine in HSV-2 Seropositive Adults (NCT02571166)Fred Hutchinson Cancer Center2015-11-01
To Investigate the Pharmacokinetics of EPORON® and EPREX® After Subcutaneous Administration in Healthy Male Volunteers (NCT02580006)Dong-A ST Co., Ltd.2015-11-01
Curcuma Longa L in Rheumatoid Arthritis (NCT02543931)University of Arizona2015-11-01
Cetuximab IRDye800 Study as an Optical Imaging Agent to Detect Cancer During Surgical Procedures (NCT01987375)Eben Rosenthal2015-11-01
A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0143-0406 A 0.6 mmol/L in Subjects With Type 1 Diabetes (NCT02612844)Novo Nordisk A/S2015-11-01
CAMELLIA: Anti-CD47 Antibody Therapy in Haematological Malignancies (NCT02678338)Gilead Sciences2015-11-01
A Study to Compare the Pharmacokinetics of Different Formulations of AZD9977 and the Influence of Food in Healthy Male Subjects (NCT02560363)AstraZeneca2015-11-01
Chronopharmacology of Valsartan in Normotensive Subjects (NCT02631031)Ain Shams University2015-11-01
Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor (NCT02562963)Minghui Zhang2015-11-01
A Safety Study of Orally Administered BPM31510 in Healthy Subjects (NCT02486055)BPGbio2015-11-01
"Pharmacokinetic Study of Nicotinamide Riboside" (NCT02689882)University of Washington2015-11-01
PK of Efavirenz & Lopinavir Nano-formulations in Healthy Volunteers (NCT02631473)St Stephens Aids Trust2015-11-01
Safety and Immunogenicity of GPO Seasonal Trivalent Inactivated Influenza Vaccine in Healthy Thai Adults (NCT02894840)Mahidol University2015-11-01
Itacitinib Combined With INCB024360 and/or Itacitinib Combined With INCB050465 in Advanced Solid Tumors (NCT02559492)Incyte Corporation2015-11-01
Melatonin Oral Gel for Oral Mucositis in Patients With Head and Neck Cancer Undergoing Chemoradiation (NCT02630004)Spherium Biomed2015-11-01
A Study of LY3154207 on Sleep in Healthy Male Participants (NCT02603861)Eli Lilly and Company2015-11-01
A Study of Vadastuximab Talirine Given Prior to or After Allogeneic Hematopoietic Stem Cell Transplant in AML Patients (NCT02614560)Seagen Inc.2015-11-01
Pharmacokinetic and Pharmacodynamics of B12019 and Neulasta® in Healthy Subjects (NCT02629562)Cinfa Biotech2015-11-01
[18F]FLT PET/CT in Rb+ Metastatic Breast Cancer (NCT02608216)University of Pennsylvania2015-11-01
Effect of Imatinib on Suppression of Malaria Parasites in Patients With Uncomplicated Plasmodium Falciparum Malaria (NCT02614404)HuLow2015-11-01
Study to Compare the Safety and Pharmacokinetics of CKD-397 (NCT02645890)Chong Kun Dang Pharmaceutical2015-11-01
Assessment of the Safety of SAR342434 and Humalog® When Administered as Continuous Subcutaneous Insulin Infusion (NCT02603510)Sanofi2015-11-01
Autologous Bone Marrow Mesenchymal Stem Cells in the Treatment of Patients With Amyotrophic Lateral Sclerosis (NCT02881489)University of Warmia and Mazury2015-11-01
A Clinical Trial on Hepatitis B Vaccine Activated-Dendritic Cells Combined With Anti-HBV Drugs in CHB (NCT02615639)Third Affiliated Hospital, Sun Yat-Sen University2015-11-01
PK of Clindamycin and Trimethoprim-sulfamethoxazole in Infants and Children (NCT02475876)Michael Cohen-Wolkowiez2015-11-01
Single Dose Study of PF-06815345 in Healthy Subjects (NCT02654899)Pfizer2015-11-01
← Previous Next →

Track Phase 1 automatically

Every clearance here is in the API, with alerts when new ones post.